Diligence memo · auto-generated · as of July 2, 2026
PathCision Medicine, Inc.
PathCision Medicine, Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
PathCision Medicine, Inc. operates in Biotechnology, based in WATERTOWN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
PathCision Medicine, Inc. has raised $2.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.7M on 2022-11-10.
Most recent recorded round closed around 2022-11-10.
Valuation (modeled)modeled
Provath models PathCision Medicine, Inc. at approximately $20M (range $1.2M–$85M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.44× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era. Within the normal band (144% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 7 months.
Last raise 3.6 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round was 3.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 30% of Biotechnology peers (4293 compared).
Modeled value ranks above 29% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.